HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.

AbstractBACKGROUND:
Studies suggest that nasal treatment might influence lower airway symptoms and function in patients with comorbid rhinitis and asthma. We investigated the effect of intranasal, inhaled corticosteroid or the combination of both in patients with both pollen-induced rhinitis and asthma.
METHODS:
A total of 262 patients were randomized to 6 weeks' treatment with intranasal fluticasone propionate (INFP) 200 microg o.d., inhaled fluticasone propionate (IHFP) 250 microg b.i.d., their combination, or intranasal or inhaled placebo, in a multicentre, double-blind, parallel-group study. Treatment was started 2 weeks prior to the pollen season and patients recorded their nasal and bronchial symptoms twice daily. Before and after 4 and 6 weeks' treatment, the patients were assessed for lung function, methacholine responsiveness, and induced sputum cell counts.
RESULTS:
Intranasal fluticasone propionate significantly increased the percentages of patients reporting no nasal blockage, sneezing, or rhinorrhoea during the pollen season, compared with IHFP or intranasal or inhaled placebo. In contrast, only IHFP significantly improved morning peak-flow, forced expiratory volume in 1 second (FEV1) and methacholine PD20, and the seasonal increase in the sputum eosinophils and methacholine responsiveness.
CONCLUSIONS:
In patients with pollen-induced rhinitis and asthma, the combination of intranasal and IHFP is needed to control the seasonal increase in nasal and asthmatic symptoms.
AuthorsR Dahl, L P Nielsen, J Kips, A Foresi, P Cauwenberge, N Tudoric, P Howarth, D H Richards, M Williams, R Pauwels, SPIRA Study Group
JournalAllergy (Allergy) Vol. 60 Issue 7 Pg. 875-81 (Jul 2005) ISSN: 0105-4538 [Print] Denmark
PMID15932376 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Allergens
  • Androstadienes
  • Anti-Inflammatory Agents
  • Fluticasone
Topics
  • Administration, Inhalation
  • Administration, Intranasal
  • Adult
  • Allergens
  • Androstadienes (administration & dosage)
  • Anti-Inflammatory Agents (administration & dosage)
  • Asthma (drug therapy, epidemiology)
  • Comorbidity
  • Double-Blind Method
  • Female
  • Fluticasone
  • Humans
  • Male
  • Middle Aged
  • Pollen (adverse effects)
  • Rhinitis, Allergic, Seasonal (drug therapy, epidemiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: